TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
DNA

Ginkgo Bioworks Holdings

Healthcare · Biotechnology

10.30$ +19.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DNA
Line item 2019 2020 2021 2022 2023 2024 2025
-1.55 -4.26 -7.46 -6.01 -6.08 -6.16 -3.08
0.37 0.44 0.85 1.01 1.47 1.21 1.06
0.03 0.01 47.22 45.97 4.73 2.16 1.47
1.86 0.11 47.30 44.28 – – –
0.37 -0.83 -1.81 -0.88 0.61 -1.73 -0.79
0.77 1.81 1.66 1.24 0.84 1.21 0.14
-2.60 -2.11 -2.15 -1.60 -1.66 -1.20 -4.33
– – 44.39 0.02 – – –
-0.01 2.86 -0.74 -0.60 0.00 0.00 0.35
6.91 -0.02 -0.03 2.33 -0.03 -0.02 -0.01
14.29 2.83 45.11 2.27 -0.07 -0.03 0.32
10.13 -3.53 35.49 -5.32 -7.82 -7.40 -7.09
-2.33 -6.08 -9.13 -7.25 -6.92 -7.36 -3.22

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?